Showing 3121-3130 of 5621 results for "".
- RetinAI Announces Collaboration with Novartis to Provide Artificial Intelligence Solutions in Ophthalmologyhttps://modernod.com/news/retinai-announces-collaboration-with-novartis-to-provide-artificial-intelligence-solutions-in-ophthalmology/2478636/RetinAI Medical announced a multi-year collaboration with Novartis Pharma under which RetinAI’s IT solutions and artificial intelligence tools will be used to support multiple projects in ophthalmology and digital health. Financial terms of the deal were not disclosed. The first pro
- Research Finds Little Progress on Worldwide Blindness in a Decadehttps://modernod.com/news/research-finds-little-progress-on-worldwide-blindness-in-a-decade/2478612/Sobering new statistics released by the
- Hospital Operating Margins Down Nearly 20% Since Start of Year Due to COVID-19, Report Sayshttps://modernod.com/news/hospital-operating-margins-down-nearly-20-since-start-of-year-due-to-covid-19-report-says/2478609/Hospitals and health system operating margins fell nearly 20% since the start of 2020 as COVID-19 continues to roil provider finances, according to a new report from Kaufman Hall, FierceHealthcare
- JetBlue, Virgin Atlantic Set to Roll Out COVID-19 ‘Health Pass’ App in Decemberhttps://modernod.com/news/jetblue-virgin-atlantic-set-to-roll-out-covid-19-health-pass-app-in-december/2478593/Following a successful test with United Airlines in October, four more major airlines plan to start offering passengers a digital health pass to certify they are COVID-19-free, according to a FierceHealthcare
- Despite Impressive Data, FDA’s Coronavirus Vaccine Reviews Will Take Weeks, Not Days, Official Sayshttps://modernod.com/news/despite-impressive-data-fdas-coronavirus-vaccine-reviews-will-take-weeks-not-days-official-says/2478574/As leading COVID-19 vaccines post positive phase 3 data and near FDA submissions, the agency official in charge of reviewing vaccines is emphasizing transparency and patience during the high-stakes process, according to a FiercePharma
- IRIS Registry Reveals Insights into Eye Disease Prevention and Treatmenthttps://modernod.com/news/worlds-largest-specialty-clinical-data-registry-reveals-insights-into-eye-disease-prevention-and-treatment/2478566/The IRIS Registry powered a number of big data studies this year, many of which were presented at AAO 2020 Virtual, the 124th annual meeting of the American Academy of Ophthalmology. The research findings are now available to view on demand. “With a growing pool of aggregated d
- EU Seals Deal For Up to 300 Million Doses of Pfizer, BioNTech’s COVID-19 Vaccinehttps://modernod.com/news/eu-seals-deal-for-up-to-300-million-doses-of-pfizer-biontechs-covid-19-vaccine/2478528/The European Commission on Wednesday said it has finalized an advance purchase agreement with Pfizer and BioNTech for the initial supply of 200 million doses of their experimental COVID-19 vaccine, with an option to request up to a 100 million more. The announcement comes days after the companies
- Llama ‘Nanobodies’ May Yield COVID-19 Treatment, Pitt Scientists Sayhttps://modernod.com/news/llama-nanobodies-may-yield-covid-19-treatment-pitt-scientists-say/2478500/Could Wally the llama hold the key to COVID-19? The immune system of the black-coated animal, who lives on a farm in Massachusetts, was coaxed into producing “nanobodies” — smaller cousins of antibodies — that neutralized the coronavirus in laboratory experiments, University of Pitt
- Lilly Reaches Deal to Supply US With COVID-19 Antibody Treatment Bamlanivimabhttps://modernod.com/news/lilly-reaches-deal-to-supply-us-with-covid-19-antibody-treatment-bamlanivimab/2478472/Eli Lilly announced that it has signed a $375-million agreement with the US government to supply 300,000 vials of bamlanivimab, an investigational neutralizing antibody treatment for COVID-19. The company recently submitted a request to the FDA seeking emergency-use authorization (EUA) for bamlan
- Allergan Announces Updates to Eye Care Optometric Professional Relations Teamhttps://modernod.com/news/allergan-announces-updates-to-eye-care-optometric-professional-relations-team/2478432/Allergan Eye Care announced the retirement of Dave Gibson, Associate VP of Consumer Eye Care and Customer Development, after 20 years of service. Since 2009, Mr. Gibson has led Allergan’s Optometric Professional Relations team and helped launch a variety of programs to support the optometry com